Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

UC Davis Health’s Melissa Jost Earns 2022 Stoltenberg Future Fund Health IT Leadership Scholarship


“My true passion is to use my background in EHR development and implementation, clinician wellbeing, and healthcare operations to advance the care we provide through our nation’s healthcare systems,” Jost said.

Stoltenberg Consulting Inc., a leading healthcare IT consulting firm, today named Melissa Jost, who serves as both the Director of Informatics and Director of Clinician Health and Wellbeing at UC Davis Health, as the recipient of the 2022 Stoltenberg Future Fund Scholarship for College of Healthcare Information Management Executives (CHIME) education.

The Stoltenberg Future Fund awards scholarships annually through the CHIME Education Foundation for recipient use at any of CHIME’s events, including the Healthcare CIO Boot Camp, CISO Boot Camp, Clinical Informatics Boot Camp, Fall CIO Forum and ViVE Conference. By supporting emerging health IT leaders, the scholarship channels industry-leading best practices for digital health advancement and interoperability into hospitals and health systems, enabling them to optimize IT systems for cross continuum care alignment. Scholarship demand has risen as pandemic recovery financial concerns have forced many hospital IT departments to cut funding for user group meetings, conferences and continuing education opportunities.

“CHIME has provided valuable mentorship and connections with leaders around the nation facing similar challenges, who I frequently rely on to develop new ideas and share lessons learned. The CHIME community has taught me not only how to address the challenges of health IT usability, adoption, and change management, but also how to become a better clinical informatics leader,” Jost said. “The gracious gift from Stoltenberg Consulting will allow me to further develop my leadership skills through CHIME to prepare for future leadership positions with UC Davis Health.”

As the inaugural Director of Clinical Informatics at UC Davis Health, Jost piloted and led the nationally-recognized Practice Experience Program (PEP) to reduce EHR burden and boost physician efficiency and satisfaction. Focusing on individually tailored EHR training, system optimization and workflow redesign, Jost deployed the PEP to over 1,800 physician faculty, residents and fellows, reducing physician time spent working after hours. She also oversaw the creation of a MyChart Message Response Team consisting of RNs, which manages 23,000 Primary Care messages per month across the UC Davis Health enterprise—improving turnaround time with 97% of messages being handled within 48 hours and reducing messages requiring physician intervention by 70%. Directly addressing the qualified IT staffing shortage plaguing healthcare, she also guided the creation of the Clinical Informatics Externship Program to provide a more diverse candidate pipeline into clinical informatics and health IT positions.

Prior to her current role, she served as a Senior Clinical Applications Analyst and Clinical Applications Project Manager at UC Davis Health, where she managed Epic implementation initiatives across all phases for revenue cycle, OR, anesthesia, patient access, radiology and referrals. She received the UC Davis Health Employee Excellence Team Award in 2020 and the STAR Award in 2019, along with the 2020 Josie King Hero Award. Jost plans to utilize the Stoltenberg Future Fund Scholarship toward her CHIME22 Fall Forum attendance in San Antonio.

Stoltenberg Consulting committed to hosting the annual CHIME Education Foundation scholarship over a span of 25 years. Jost is the 13th scholarship recipient of the Stoltenberg Future Fund program since its inception in 2009. To be eligible for this scholarship, applicants must be CHIME members in good standing, express need for financial support for continuing education and describe their professional accomplishments and aspirations in the healthcare IT industry. Previous recipients include IT leaders from Ascension Saint Thomas, Dayton Children’s Hospital, Texas Children’s Hospital, UNC Health Care, Brooke Army Medical Center, UPMC Chautauqua and Jackson Health System.

To learn more about the Stoltenberg Future Fund Scholarship, visit https://www2.stoltenberg.com/Scholarship.

About Stoltenberg Consulting

For over 27 years, Stoltenberg Consulting has exclusively served the healthcare industry by providing customizable IT support solutions. FlexSourcing, Stoltenberg Consulting’s three-time Best in KLAS Partial IT Outsourcing program, delivers day-one ROI through a versatile, certified health IT support workforce—including Tier 1+ help desk services—that can scale up at any time. Averaging 15 years of experience, Stoltenberg analysts are skilled in both financial and clinical systems with best practice expertise for Epic, Oracle Cerner, MEDITECH, NextGen, Allscripts and eClinicalWorks systems. To see how Stoltenberg simplifies healthcare technology, visit stoltenberg.com.

Share article on social media or email:

FitOn Health Launches Fall Prevention Program for Older Adults


News Image

FitOn, the No. 1 fitness app and digital health & wellness platform, today announced the launch of its Fall Prevention series on its FitOn Health platform for employers and health plans. Geared to help older adults take action to prevent falls from happening, this is the latest health course available for those looking to lead a healthier lifestyle without the need for expensive equipment or treatments.

Led by renowned fitness trainer and fall prevention specialist, David Jack, the program focuses on the necessary steps to avoid falls. This includes fall-proofing a home, learning balance and strength exercises and avoiding common mistakes that leave people vulnerable to falling. The course helps people to assess their risks, remove dangers inside and out of the home, overcome the stigma associated with falling and receive the support they need to enjoy life.

Every year, three million adults over 65 years old are treated in emergency departments for fall injuries that cost up to $50 billion in medical expenses annually, with 3/4 paid by Medicare and Medicaid. While not all falls are preventable, it is estimated that 20–30% of falls can be prevented by assessing risks and intervening to reduce these risks.

“Over 800,000 people are hospitalized annually due to falling and receiving a head injury or hip fracture. Such injuries can be costly to both patients and health insurers and a fear of falling begins to develop,” said Lindsay Cook, Founder and CEO of FitOn. “This fall prevention course empowers people to overcome this fear by assessing the risk, building up strength through functional exercises and taking steps to ensure their home is fall-proof. This course will also help members caring for aging parents by providing education and tips on how they can better communicate and mitigate fall related issues with aging loved ones”.

“Falls can lead to injuries, broken bones or even death and the fear of falling may cause a person to be less active in their everyday activities. In turn, they become weaker and their chances of falling increase,” says David Jack, course trainer of FitOn Health’s Fall Prevention program. “This course was developed with FitOn Health to focus on identifying a preventive process to help revive your body and significantly reduce the likelihood of falling.”

The expansion of FitOn Health’s course offerings comes off the heels of FitOn’s recent Peerfit acquisition earlier this year, which provides fitness and wellness benefits to employers and members nationwide through its deep relationship with leading health providers. Working in close partnership with its health plan partners, FitOn Health has introduced a range of care management courses on topics that address key areas of focus for plan members.

“Fall prevention is a big risk for individuals as they age and this program is an excellent resource to help seniors make changes to make their homes and keep themselves safe,” says Steven Selinsky, Vice President of Government Programs, Product, & Community Outreach for HAP, a current client that offers health insurance plans for individuals, families, employer groups and Medicare and Medicaid members. “Courses like this one from FitOn Health are great because they are easily accessible, can be watched at the member’s convenience, have very useful content from industry experts and can be shared with caregivers. The FitOn platform along with the benefits Peerfit provides helps individuals have access to information, platforms and resources to meet their health and wellness needs and live an active lifestyle.”

The Fall Prevention course includes 13 lessons and is immediately available to anyone with access to FitOn Health through their health plan or employer.

For more information, visit: https://web.fitonapp.com/course/fall-prevention

About FitOn Health

FitOn Health provides employers and health plans with FitOn’s premium digital fitness and hybrid health experiences to support the wellbeing of their employees, members and businesses. FitOn Health provides the tools for organizations to drive best-in-class engagement and measure the success of the program. It’s a one-stop wellness solution that can help your employees and members get more active, connect with coworkers, friends and family, and make leading a healthy lifestyle fun and motivating. Learn more at: https://health.fitonapp.com

For more information, please contact: press@fitonapp.com

Share article on social media or email:

Labrador Systems Announces First Business Customers of its Award-Winning Personal Assistive Robots


“The burden on caregivers is growing at a rate that is simply not sustainable. Organizations are already experiencing major caregiver shortages, and in the coming years there will be significantly more people 85+ with fewer people to help take care of them,” Mike Dooley, CEO of Labrador Systems.

Labrador Systems today announced the first reservations for the initial production of its assistive robots from several leading organizations in home care and senior living. First announced in January at CES 2022, the award-winning Labrador® Retriever personal robot empowers people to live more independently and extends the impact of caregivers. The assistive robot lightens the load of daily activities by physically bringing essential items within reach. Labrador will offer home care and senior living organizations a professional grade version of the robot, the “Retriever Pro,” with additional features to help caregivers and staff manage client care.

Labrador will make the Retriever Pro available as a service, creating fleets of robots for care providers to deploy to support individuals in a variety of settings. Organizations set to receive the first deliveries of the Retriever Pro include: On Lok PACE, Nationwide Insurance, Masonic Homes of California, Western Homes Communities, Eskaton, The Perfect Companion, Presbyterian Villages of Michigan, University of Michigan Flint, and Graceworks Lutheran Services.

The Retriever is the first autonomous robot of its kind to be deployed in homes at this scale to physically assist individuals with a range of daily activities.

The reservations follow Labrador’s groundbreaking series of pilot studies, where the company’s personal assistive robots were successfully deployed in the homes of a diverse mix of individuals with different needs and conditions. A video with testimonials from the initial pilot users is viewable at https://youtu.be/aTOyXBr9VyU.

“Our partnership with Labrador during the pilot enabled Nationwide to observe firsthand the impact the Retriever can have on individuals’ daily lives,” said Bobbi Jo Allan, Nationwide’s Vice President of Innovation. “As champions for helping people live as independently as possible, we’re excited at the prospect of continuing to learn alongside Labrador Systems about how best to support independent living. We look forward to deploying our own small number of robots to focus even more deeply on innovative ways we can provide value to our customers.”

“Labrador is at the forefront of creating an entirely new category of assistive robots.” added Micah Fening, Innovation Director at Nationwide. “We haven’t seen any other personal robot for the home with the Retriever’s capabilities.”

The Retriever Pro is designed to assist individuals where pain, injury or other health conditions impact their daily activities. It is large enough to carry items such as a laundry basket but agile enough to navigate the tight spaces of a home. The Retriever Pro also features an innovative retrieval and delivery system to bring items within reach, enabling caregivers to set up items for delivery when they are not present. Caregivers and users can easily command the Retriever Pro using their smartphone or with their voice through an Alexa-enabled device.

“The burden on caregivers is growing at a rate that is simply not sustainable. Organizations are already experiencing major caregiver shortages, and in the coming years there will be significantly more people in my parents’ age group (85+) with fewer people to help take care of them,” said Mike Dooley, CEO of Labrador Systems. “Our mission is to provide relief on both sides of that equation, empowering individuals who need care to do more on their own while extending the impact of each caregiver’s visit well beyond the time they are physically present.”

Labrador Charter Customers

To validate the product and gather feedback on the Retriever, Labrador worked with a range of organizations to place pilot robots into homes for real-world testing.

One such organization, On Lok, was founded 50 years ago in San Francisco as a nonprofit to empower older adults to age with dignity and independence. The organization pioneered PACE, the Medicare- and Medicaid-funded Program of All-Inclusive Care for the Elderly, which enables nursing home-eligible seniors to continue to live in their home and receive care and support in their own community.

“On Lok is excited to be one of the first healthcare organizations to bring the Retriever Pro into homes and continue to pioneer the future of care,” said Michael Webb, Chief Technology Officer at On Lok. “We are continuously looking for opportunities to enhance the support we provide to seniors and provide excellent quality of care to help them age with dignity. Labrador offers unique new ways to help us do this, and support our On Lok PACE participants, as well as assist our caregivers.”

Labrador’s pilots included tests and site visits with senior living communities, such as Masonic Homes of California, established in 1898.

“Our on-campus test of Labrador robots created quite an impression, generating excitement among our community,” said James MacRae, Innovation Project Manager of Masonic Homes CA. “We are eager to deploy our own fleet of Labrador Retriever Pros because it supports our mission to provide best-in-class experiences for our residents while allowing our caregivers to deliver high-touch personal care.”

With the announcement of the reservations for the Retriever Pro, the company also continues to move forward with development and testing of the standard version of the Retriever announced earlier this year.

###

About Labrador Systems, Inc.

Labrador Systems is an early-stage robotics company developing a new generation of assistive robots to help individuals live more independently and extend the impact of caregivers. The company’s core focus is creating affordable solutions that address practical and physical needs at a fraction of the cost of commercial robots. Labrador Systems’ investors include SOSV/HAX, Amazon’s Alexa Fund, iRobot Ventures, Grep VC and SkyRiver Ventures. Labrador was awarded a National Science Foundation Phase I SBIR Grant in 2021 and a Joseph F. Engelberger Foundation Robotics Grant for Elder Care in 2022. For more information, visit

http://www.labradorsystems.com.

Share article on social media or email:

PetMeds® Celebrates Senior Pets With “Fur-ever Young” Giveaway


News Image

“While nobody likes to think about their pet getting older, the senior years are a truly special time,” says Larissa Schenck, Director of Marketing at PetMeds®. “Cats and dogs become more settled down, more relaxed, and ready to enjoy an even deeper bond with their favorite humans.”

November is Senior Pet Month, dedicated to raising awareness of the perks of adopting a senior cat or dog as well as the importance of proper care and an active lifestyle to extend their happy, healthy years.

While every pet ages differently, a cat is generally considered a senior by the time they are ten years old. Dogs enter their senior years between five and ten years old, with smaller breeds aging more slowly than large dogs.

Over the past forty years, the average life expectancies of cats and dogs have nearly doubled. Pets are living longer due to higher standards in care and nutrition and advancements in veterinary science. It is not unusual for senior cats and dogs to live to celebrate their tenth, fifteenth, and even twentieth birthdays.

To keep middle-aged and senior pets in their best health for as long as possible, proper veterinary care is essential. Annual or twice-yearly wellness visits can catch illness early. Early intervention can be highly beneficial for common conditions seen in senior pets including kidney disease, diabetes, dental disease, and osteoarthritis.

Most cats and dogs will develop osteoarthritis in at least one joint in their lifetime. Pet parents can prevent or slow the progression by giving joint supplements at any age. For pets with osteoarthritis there are many effective pain management options including physical therapy, medications, holistic remedies, laser therapy, and acupuncture, making it possible for cats and dogs to stay active, healthy, and comfortable throughout their senior years.

“While nobody likes to think about their pet getting older, the senior years are a truly special time,” says Larissa Schenck, Director of Marketing at PetMeds®. “Cats and dogs become more settled down, more relaxed, and ready to enjoy an even deeper bond with their favorite humans.”

PetMeds® is celebrating senior pets by giving away Special Senior Support Prizes Packs containing Vetoquinol Pill Wraps, NaturVet Digestive Enzymes Plus Probiotic Powder, and HomeoPet Anxiety Relief every Friday in November. Dog prize packs will also include Zesty Paws Senior Advanced 11-in-1 Bites, and Cat prize packs will also include Soft VitaChews for Cats. All pet parents are invited to enter the “Fur-ever Young” giveaway at https://bit.ly/furreveryoung

The giveaway runs from November 2, 2022, through November 30, 2022. Everyone who enters from 12:01 AM Eastern Time (“ET”) November 2, 2022, to November 30, 2022, at 11:59 PM ET is eligible to win a cat or dog care pack. One cat and one dog winner will be chosen each week for a total of eight (8) winners.

ABOUT PETMEDS

Founded in 1996, Petmeds.com is Your Trusted Pet Health Expert, providing fast, easy and helpful service to over 10 million customers across North America. PetMeds® delivers prescription and non-prescription medications and pet supplies for less, direct to the consumer through its PetMeds® toll-free number, on the Internet through its website Petmeds.com, or with the PetMeds® free mobile app available for Apple and Android devices.

Share article on social media or email:

Biotechnology Innovators Honored in 2022 BioTech Breakthrough Awards Program


News Image

It’s an exciting time in the industry and we are thrilled to highlight the ‘breakthrough’ biotechnology solutions, services and companies around the world for our 2022 program – Bryan Vaughn, Managing Director of BioTech Breakthrough Awards

BioTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout life sciences and biotechnology companies, products and services around the globe, today announced the results of the second annual BioTech Breakthrough Awards program. The winning BioTech Breakthrough selections for 2022 showcase life sciences and biotechnology companies that push ingenuity and exemplify the best in biotech solutions across the globe.

The mission of the annual BioTech Breakthrough Awards program is to conduct the industry’s most comprehensive analysis and evaluation of the top companies, solutions and products in the life sciences and biotechnology industry today. This year’s program attracted more than 1,350 nominations from over 12 different countries throughout the world. Categories include: BioPharma, Genomics, Therapeutics, Food Science, Immunology, BioServices and more.

“Advances in biological sciences, combined with accelerating development of computing, data processing, and AI are fueling a new wave of innovation in the healthcare sector. These advances are providing new understanding, new materials, new tools, as well as lower costs. We’re seeing trends in use of next-generation computing technology, growth in personalized treatment of rare diseases, vaccine development and the advancement of cell and gene therapies, to name a few,” said Bryan Vaughn, Managing Director of BioTech Breakthrough Awards. “It’s an exciting time in the industry and we are thrilled to highlight the ‘breakthrough’ biotechnology solutions, services and companies around the world for our 2022 program. We extend our sincerest congratulations to our 2022 BioTech Breakthrough Award winners.”

The 2022 BioTech Breakthrough Awards program winners include:

BioPharma

Vaccine Innovation of the Year: Fast Track Automation, Honeywell

Overall BioPharma Solution of the Year: Scientist.com

Overall BioPharma Company of the Year: Boundless Bio

Genomics

Overall Genomics Innovation of the Year: Colossal Biosciences

Therapeutics

Therapeutics Solution of the Year: PharmaEssentia

Therapeutics Innovation of the Year: Cartography Biosciences

Diagnostics

Diagnostics Company of the Year: Longhorn

Immunology

Cancer Immunology Solution of the Year: Promontory Therapeutics

Overall Immunology Company of the Year: Ozette Technologies

Data & Analytics

Analytics Solution of the Year: Waters Corporation

Predictive Analytics Solution of the Year: VeriSIM Life

Analytics Solution Provider of the Year: Saama Technologies

Nutraceuticals

Nutraceutical Innovation of the Year: Brightseed

Medical Technology

Oncology Innovation of the Year: Imagene AI

MedTech Solution of the Year: Abbott

BioAgriculture

BioAg Breeding Solution of the Year: Dewey Scientific

Overall BioAgriculture Solution of the Year: C16 Biosciences

Overall BioAgriculture Company of the Year: Solis Agrosciences

BioInformatics

BioInformatics Company of the Year: Golden Helix

Industry Leadership

BioTech Company CEO of the Year: James Peyer, Ph.D., Cambrian Biopharma

BioTech Startup of the Year: Abata Therapeutics

BioTechnology Innovator of the Year: PTC Therapeutics

Overall BioTech Company of the Year: Vizgen

####

About BioTech Breakthrough

Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the BioTech Breakthrough Awards program is devoted to honoring excellence in life science and biotechnology solutions, services and companies. The BioTech Breakthrough Awards provide public recognition for the achievements of biotechnology companies and products in categories including BioPharma, Genomics, Therapeutics, Food Science and BioAgriculture, and more. For more information visit BioTechBreakthroughawards.com

Share article on social media or email:

MCG Interoperability Experts to Speak at HLTH 2022 Conference


MCG Health

MCG Health, part of the Hearst Health network

“This issue is critical to address, which is why we are looking forward to sharing how both payers and providers can reduce this administrative burden by using AI solutions.” – Rajesh Godavarthi, Associate VP of Technology and Interoperability, MCG Health

MCG Health, part of the Hearst Health network and an industry leader in technology-enabled, evidence-based guidance, announces four of its interoperability experts will present two sessions at HLTH 2022 happening November 13-16, 2022, in Las Vegas, Nevada. The HLTH event brings together leaders from across the healthcare ecosystem to encourage connections and thought-provoking discussions that push the boundaries of health innovation.

Daniel Cawood, MCG Product Manager of Interoperability Solutions, and Nick Engelhardt, MCG Senior Product Owner of Interoperability Solutions, will present the first technology talk, “Reducing Administrative Burden in Admission Authorizations,” on November 14, 2022, at 3:20 p.m. (PT). This session will discuss how MCG helped automate manual authorization submissions directly from the providers’ EHR between a payer and two hospitals for emergent inpatient admissions.

Natalie McGarry, MCG Senior Product Owner, and Rajesh Godavarthi, MCG Associate Vice President of Technology and Interoperability, will present the second tech talk, “Reducing Administrative Burden in Elective Procedure Authorizations,” on November 15, 2022, at 11:05 a.m. (PT). This presentation will cover how MCG helped automate manual authorization submissions for elective procedure admissions using the HL7 ® Da Vinci Project’s Implementation Guides’ (IGs) specifications.

“The healthcare industry has struggled with the authorization process for decades,” said Godavarthi. “CAQH’s Index from 2021 estimates that 35% of prior authorization requests in 2021 were submitted in a fully manual fashion (phone, fax, email, mail). This issue is critical to address, which is why we are looking forward to sharing how both payers and providers can reduce this administrative burden by using AI solutions.”

Daniel Cawood oversees the product development for MCG’s interoperability solutions and connecting payers and providers for authorization processes. Mr. Cawood began his time at MCG overseeing the Indicia suite of solutions (provider market clinical decision support) and value-based care solutions.

Nick Engelhardt is the Senior Product Owner for MCG’s interoperability solutions. Prior to joining MCG in March of 2022, he worked as a program manager for utilization management operations and care management operations at a large health system based in Cleveland, Ohio. Mr. Engelhardt’s experience in utilization and care management allows him to better understand the unique relationship between payers and providers. His work in interoperability solutions focuses on removing administrative burdens from clinical teams within payers and providers, creating a more efficient transaction that, ultimately, improves patient care.

Natalie McGarry has been with MCG for four years and is a Senior Product Owner for interoperability solutions. Her primary area of focus is building products that reduce administrative burdens. Before joining the interoperability team, Natalie was the Product Owner for MCG’s provider-facing solutions.

Rajesh Godavarthi has been with MCG Health since 2002. MCG is an Associate Member of the HL7® Da Vinci Project and Mr. Godavarthi leads the development efforts for that partnership. Prior to MCG, he was the Development Lead at Milliman and a lead developer at Intel. He received his Master’s in Computer Science from Osmania University.

For those interested in attending HLTH 2022, registration details and additional information can be found at: https://www.hlth.com/2022event.

###

About MCG Health

MCG, part of the Hearst Health network, provides unbiased clinical guidance that gives healthcare organizations confidence in delivering patient-centered care. MCG’s artificial intelligence and technology, infused with clinical expertise, enables its clients to prioritize and simplify their work. MCG’s world-class customer service ensures that clients maximize the benefits of licensing MCG solutions – demonstrating improved clinical and financial outcomes. For more information visit http://www.mcg.com or follow our Twitter handle at @MCG_Health.

About Hearst Health

The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Care guidance from Hearst Health reaches the majority of people in the U.S. The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase and MHK (formerly MedHOK). Hearst also holds a minority interest in the precision medicine and oncology analytics company M2Gen. Follow Hearst Health on Twitter @HearstHealth and LinkedIn @Hearst-Health.

Share article on social media or email:



New Republic Partners Makes Strategic Investment in Innovation Fertility


Innovation Fertility, a network of leading IVF clinics and laboratories that provide IVF services and infertility care across the country, announced today an investment by New Republic Partners, an investment management and wealth advisory firm. The firm joined with Albaron Partners, the current owner of Innovation Fertility, to provide capital to support the long-term growth strategy of the healthcare platform.

The $8B U.S. fertility market includes in-vitro fertilization, genetic testing, reproductive tissue storage and donor services. This market continues to benefit from long-term demand drivers and strong growth rates.

Sam Bowles, managing director at New Republic Partners, says, “Albaron Partner’s deep experience in this industry coupled with strong market expansion opportunities makes this an attractive investment opportunity.”

Innovation Fertility is led by Dwight Ryan, chief executive officer, a seasoned healthcare executive with extensive years of financial, accounting and operations experience within the infertility industry, and Dr. Kathleen Miller, Chief Science Officer, a world-known leader for research advances in the field of blastocyst culture and pre-implantation genetics as well as a leading expert in laboratory management, quality improvement programs, and single embryo transfer.

Innovation Fertility provides patients with innovative, cutting-edge fertility treatment options to meet their unique family planning goals. As a team, they combine premier reproductive endocrinologists with laboratory operations, resulting in exceptional medical care and an unparalleled patient experience.

The organization’s growth strategies include plans to invest in practices across the U.S. to enable practice growth and profitability. Current investment holdings include practices in North Carolina, Ohio, Michigan and Montana.

About Us

Innovation Fertility

Innovation Fertility provides patients with innovative, cutting-edge fertility treatment options to meet their unique family planning goals. As a team, they combine premier reproductive endocrinologists with laboratory operations, resulting in exceptional medical care and an unparalleled patient experience. Learn more at http://www.iffertility.com.

New Republic Partners

New Republic Partners is an innovative investment management and wealth advisory firm serving successful individuals and families, endowments and foundations. Our clients benefit from access to investment opportunities usually reserved for large institutional investors, bespoke asset-class-specific fund offerings, customized portfolios, complex planning, and the expertise and experience of a successful and seasoned investment management, wealth advisory and credit solutions team. The firm is headquartered in Charlotte, North Carolina. More information is available at http://www.newrepublicpartners.com

Albaron Partners

Albaron is a U.S. private equity firm that invests in and helps accelerate the growth of physician practice groups and microcap healthcare companies. The firm’s goal is to build best-in-class healthcare services platforms that maximize outcomes for all constituents – patients, providers, payors and investors. Albaron’s team is comprised of a seasoned cohort of operating experts and investment professionals who are uniquely qualified to realize significant value through strategic insights, operating support and accretive acquisitions. The team works collaboratively with management teams and leverages its network of industry experts to augment its capabilities. For more information, visit http://www.albaronpartners.com.

Forward-Looking Statement

This communication expressly or implicitly contains certain forward-looking statements that involve risks and uncertainties. If any of these risks or uncertainties materialize, or assumptions by New Republic Partners, Albaron Partners or Innovation Fertility prove incorrect, results could differ materially from the results expressed or implied by these forward-looking statements. All forward-looking statements in this communication are based on information available to New Republic Partners, Albaron Partners and Innovation Fertility as of the date of this communication, and New Republic Partners, Albaron Partners and Innovation Fertility do not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.

Share article on social media or email:

Top Trainer for Galderma and Allergan Opens New Aesthetic Injection Company in Scottsdale


Marissa Abdo, MS, RN, CANS

“Our service is unique in that we concentrate on a person’s anatomy when injecting in order to help clients attain the most beautiful results for their particular facial structure,” said Marissa Abdo, Aesthetic IQ Founder.

Marissa Abdo, MS, RN, CANS, a former team member of Beverly Hills’ Dr. 90210, has opened her own clinic in Scottsdale called Aesthetic IQ to help patients reach their full potential with specialized facial injectable treatments that include Botox, Dysport, Juvederm and Restylane dermal fillers, and Sculptra Aesthetic.

Abdo is a top national trainer for Allergan and Galderma with over a decade of industry experience. She specializes in natural, safe, and impactful injectable treatments and focuses on the anatomy of her clients’ facial structures to enhance their overall beauty. Abdo established Aesthetic IQ, a brand-new, exclusive medical aesthetic clinic, using her expertise as a national educator to provide clients looking to improve their looks with a completely unique experience.

“Your injectable procedures should not only enable you to present your finest face, but also give you the confidence and self-assurance to do so,” said Marissa Abdo, Aesthetic IQ Founder. “Our service is unique in that we concentrate on a person’s anatomy when injecting in order to help clients attain the most beautiful results for their particular facial structure.”

The term “Aesthetic Intelligence,” from which “Aesthetic IQ” is derived, refers to using the power of the senses to produce treatments, results, and an elevated aesthetic experience while bridging the gap between the art and science of injectables. The goal of Aesthetic IQ is to provide patients with meaningful and impactful treatments as well as an immersive experience that makes them feel informed, appreciated, and confident that they are receiving the safest and most effective injectable care possible.

At the clinic, patients will be able to receive chin filler, lip augmentation, tear trough filler, non-surgical brow lift, non-surgical neck lift, cheek and jaw augmentation, and other injectable treatments.The Aesthetic IQ clinic is open Monday through Friday from 9 am-5 pm. For more information, call 480.454.5577, visit AestheticIQClinic.com or visit their location at 7054 E Cochise Rd. B200 Scottsdale, AZ 85253. You can follow the clinic on social media at – @Marissa.AestheticIQ.

About Marissa Abdo

Aesthetic IQ’s founder, Marissa Abdo, MS, RN, CANS, was formerly on the staff of Beverly Hills’ Dr. 90210 and is a preferred injector for Hollywood’s elite and celebrities. At this unique aesthetic clinic, Abdo focuses on her clients’ facial anatomy to improve their overall beauty. She is a firm believer in empowering women both through her professional services and through education. As a top national trainer for Galderma and Allergen, Abdo has trained healthcare professionals at more than 100 locations in the Scottsdale area. She is dedicated to creating an empowered community of practitioners who can safely administer injections to all patients and believes that every injector should have a seat at the table. In terms of service and outcomes, Abdo is leading the way and establishing the bar for the injection industry. Through Aesthetic IQ, she is pleased to provide each patient—from mature patients and even men—with a personalized experience. Each patient receives assistance from Abdo in realizing their beauty and their unique contribution to the world.

Share article on social media or email:

Dr. Ashley Shayter Selected Act Early Ambassador of Michigan


AAoM

AutismAlliance of Michigan

“I’m very excited to be the CDC’s Act Early Ambassador for Michigan! Empowering parents with tools to watch their child grow and thrive is so important, says Dr. Ashley Shayter. We know that early intervention is key to maximizing long-term benefits…..”

Southfield, Michigan (November 3, 2022) — The Autism Alliance of Michigan (AAoM) is pleased to announce that Dr. Ashley Shayter, PhD, LBA, BCBA-D, CBIS, Policy Manager for Statewide Education & Outreach, has been selected as CDC’s Act Early Ambassador to Michigan.

Act Early Ambassadors work with CDC’s Learn the Signs. Act Early. program to improve early identification of developmental delays and disabilities so that children and their families can access needed services as early as possible.

“This is such a significant opportunity for AAoM and our state, said Colleen Allen, Ph.D., President and CEO of AAoM. Reducing the age of diagnosis and access to critical services is one of our major strategic initiatives over the next 10 years. The Learn the Signs. Act Early. Campaign is perfectly aligned with this work. Dr. Shayter’s role as Ambassador will allow us to connect with national experts, colleagues in other states addressing this priority, and resources to share with stakeholders”.

Since 2011, professionals with medical, child development, developmental disability, special education, and early intervention expertise have been selected to serve as a state or territorial point-of-contact for the national Learn the Signs. Act Early. program. The ambassador supports the work of Act Early Teams and other Michigan-specific initiatives to improve early identification of developmental delay and disability; and promote the adoption and integration of Learn the Signs. Act Early. resources into systems that serve young children and their families.

“I’m very excited to be the CDC’s Act Early Ambassador for Michigan! Empowering parents with tools to watch their child grow and thrive is so important, says Dr. Ashley Shayter. We know that early intervention is key to maximizing long-term benefits. I hope my work as the Act Early Ambassador will encourage everyone who interacts with young children–from families to healthcare organizations to educators–to use the Learn the Signs. Act Early. materials and resources so we can ensure a bright and successful future for Michigan’s children.”

Click here to read more about CDC’s Act Early Ambassadors.

About Autism Alliance of Michigan

Since 2009, The Autism Alliance of Michigan (AAoM) has led collaborative efforts across the state that improve the quality of life for individuals with autism through education, comprehensive services, community awareness, inclusion efforts and coordinated advocacy across their lifespan. AAoM is the trusted ally and partner for thousands of families.  An AAoM navigator can be reached at 877-463-2266 (AAOM) or email at navigator@aaomi.org. For information on events, resources and donations, or for more information on the Watch Me Grow program, please visit autismallianceofmichigan.org.

# # #

Share article on social media or email:

Pediatric Multicenter Study Shows Targeted Therapy for High-Risk Hodgkin Lymphoma Reduces Relapse


We saw a 10% improvement in event-free survival — a real breakthrough. That’s quite a big gain, especially in pediatric Hodgkin lymphoma.

— A targeted therapy for children with high-risk Hodgkin lymphoma (HL) was shown to significantly reduce relapse rates when tested in a large multicenter clinical trial conducted by the Children’s Oncology Group(COG) and led by pediatric oncologists at Roswell Park Comprehensive Cancer Center, Children’s Healthcare of Atlanta and Winship Cancer Institute of Emory University. By combining the targeted antibody-drug conjugate (ADC) brentuximab vedotin (BV) with the standard chemotherapy regimen, children were 10% less likely to relapse. The findings were published today in the New England Journal of Medicine (NEJM). *

“We saw a 10% improvement in event-free survival — a real breakthrough,” says study senior author Kara Kelly, MD, Chair of the Roswell Park Oishei Children’s Cancer and Blood Disorders Program, and also Division Chief of Hematology/Oncology in the Department of Pediatrics at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo. “That’s quite a big gain, especially in this field. We expect that this treatment regimen will soon become standard of care for pediatric patients with high-risk Hodgkin lymphoma.”

The clinical trial, AHOD1331 (NCT02166463), was funded by the National Cancer Institute (NCI) of the National Institutes of Health and conducted at 153 COG sites. The study was also supported by Seagen, formerly known as Seattle Genetics, and the St. Baldrick’s Foundation. The study was sponsored by the Division of Cancer Treatment and Diagnosis, NCI, and the brentuximab vedotin was provided by Seagen under a Cooperative Research and Development Agreement with NCI.

“This trial reflects a paradigm shift for advanced-stage Hodgkin lymphoma in children, and an introduction of the first targeted approach for initial therapy in pediatric Hodgkin lymphoma and the first new regimen in two decades,” says study first author Sharon Castellino, MD, MSc, Director of the Leukemia and Lymphoma Program at the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta, Professor of Pediatrics at Emory University School of Medicine, and a research member at Winship Cancer Institute of Emory University. Dr. Castellino succeeded Dr. Kelly this year as COG Hodgkin Committee Chair. “We are optimistic that this trial will set the stage for FDA approval of this targeted antibody-drug conjugate for children and adolescents.”

Study Vice Chair and Co-Author Frank Keller, MD, Pediatric Hematologist/Oncologist at the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta and Professor of Pediatrics at Emory University School of Medicine, adds: “The demonstration of the effectiveness of a highly targeted treatment directed against the malignant cell population in newly diagnosed pediatric and young adult patients with high-risk Hodgkin lymphoma is a significant step forward toward improving cure rates and may do so without adding significant long-term toxicity for this young population with many years of life remaining.”

HL is the most common cancer in patients 12-29 years old. Although it has a high five-year survival rate — 97% of those under 19 are alive five years after diagnosis — about one-third of survivors are classified as high risk; of those, approximately 15-20% will relapse.

The COG study — the largest and only randomized phase 3 trial with the CD-30-targeted ADC ever conducted with newly diagnosed high-risk HL pediatric patients — involved 587 patients ages 2-21 with previously untreated disease.

Patients were randomized to one of two arms, both arms receiving treatment over five 21-day cycles. Those in the control group received the standard pediatric chemotherapy regimen.

The second group received the standard pediatric chemotherapy regimen, plus brentuximab vedotin. Brentuximab vedotin (BV) is an antibody-drug conjugate that specifically targets the CD30 protein on the surface of HL cancer cells, destroying them while mostly sparing healthy cells.

Both groups received site radiation therapy based on responses assessed after two cycles of treatment.

Follow-up at about three and a half years after treatment showed 92.1% event-free survival in the brentuximab vedotin group, compared with 82.5% for the control group — an overall risk reduction of 59% of relapse, death or a second malignant neoplasm.

Lower risk of relapse could possibly eliminate the need for re-treatment with additional toxic therapies. Over the long term, treatment toxicity puts HL survivors at very high risk of breast cancer, stroke, myocardial infarction, restrictive pulmonary disease, infertility and shortened lifespan.

“Brentuximab vedotin is not anticipated to have long-term toxicity,” says Dr. Kelly, noting that during the treatment phase of the clinical trial, less than 10% of patients who received it needed a dose reduction. “Because the drug could be given more consistently, its efficacy improved with no increase in neuropathy or serious infection.”

Dr. Kelly, Dr. Castellino and colleagues will build on these findings in a new clinical trial set to open in early 2023 with support from the National Cancer Institute. The phase 3 randomized study will enroll approximately 1,900 children and adults ages 5-60 with medium- and low-risk HL. The goal: to determine whether the combination of the the CD30 targeted ADC brentuximab vedotin and immunotherapy agent nivolumab can prolong progression-free survival and further reduce patients’ exposure to standard chemotherapy and radiation. Patients will be followed for 12 years to monitor their progress and gauge the results.

Allison Brashear, MD, Vice President for Health Sciences at the University at Buffalo and Dean of the Jacobs School of Medicine and Biomedical Sciences, says results of the study “mean a greatly improved quality of life for the most vulnerable and courageous patients — children with cancer.

“As one of the largest demonstrations of a successful immuno-oncologic approach in children with cancer,” Dr. Brashear notes, “it is a powerful example of what happens when extraordinary institutions decide that collaboration is key to their success.”

Lucky Jain, MD, MBA, Pediatrician-in-Chief for Children’s Healthcare of Atlanta, and Chair of the Department of Pediatrics for Emory University School of Medicine, says, “A 10 percent reduction in relapse among children with high-risk Hodgkin lymphoma is a significant milestone for the field of pediatric cancer. Children’s Healthcare of Atlanta and Emory University are proud of this incredible leap forward led by our physicians, Dr. Sharon Castellino and Dr. Frank Keller, along with their collaborators and the Children’s Oncology Group.”

*Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number NCTN Operations Center Grant U10CA180886 and NCTN Statistics & Data Center Grant U10CA180899. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

###

About Roswell Park

Roswell Park Comprehensive Cancer Center is a community united by the drive to eliminate cancer’s grip on humanity by unlocking its secrets through personalized approaches and unleashing the healing power of hope. Founded by Dr. Roswell Park in 1898, it is the only National Cancer Institute-designated comprehensive cancer center in Upstate New York. Learn more at http://www.roswellpark.org, or contact us at 1-800-ROSWELL (1-800-767-9355) or ASKRoswell@RoswellPark.org.

About Children’s Healthcare of Atlanta

As the only freestanding pediatric healthcare system in Georgia, Children’s Healthcare of Atlanta is the trusted leader in caring for kids. The not-for-profit organization’s mission is to make kids better today and healthier tomorrow through more than 60 pediatric specialties and programs, top healthcare professionals, and leading research and technology. Children’s is one of the largest pediatric clinical care providers in the country, managing more than one million patient visits annually at three hospitals, Marcus Autism Center, the Center for Advanced Pediatrics, urgent care centers and neighborhood locations. Consistently ranked among the top children’s hospitals by U.S. News & World Report, Children’s Healthcare of Atlanta has impacted the lives of kids in Georgia, across the United States and around the world for more than 100 years thanks to generous support from the community.

About Winship Cancer Institute of Emory University

As the only National Cancer Institute-designated Comprehensive Cancer Center for the state of Georgia, Winship Cancer Institute of Emory University discovers, develops, delivers and teaches some of the world’s most effective ways to prevent, detect, diagnose and treat each patient’s unique cancer. For more information, visit winshipcancer.emory.edu.

About the Jacobs School of Medicine and Biomedical Sciences at UB

The Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo is proud of its legacy advancing the best in medical education, clinical care and scientific discovery. Today, the Jacobs School is at the center of Buffalo’s comprehensive academic health center. With UB’s other four health sciences schools and its School of Social Work, the Jacobs School prepares tomorrow’s health leaders at both the lab bench and the bedside to benefit the health and wellness of the people of Western New York, New York State and the world. Founded in 1846, the school provides care for the region’s diverse population through strong clinical partnerships and its practice plan, UBMD Physicians’ Group. UB is a premier, research-intensive public university, and it is a flagship institution of the State University of New York. UB is a member of the Association of American Universities, which is composed of America’s leading research universities.

About The Children’s Oncology Group (COG)

COG (childrensoncologygroup.org), a member of the NCI National Clinical Trials Network (NCTN), is the world’s largest organization devoted exclusively to childhood and adolescent cancer research. COG unites over 10,000 experts in childhood cancer at more than 200 leading children’s hospitals, universities, and cancer centers across North America, Australia, and New Zealand in the fight against childhood cancer. Today, more than 90% of the 16,000 children and adolescents diagnosed with cancer each year in the United States are cared for at COG member institutions. Research performed by COG institutions over the past 50 years has transformed childhood cancer from a virtually incurable disease to one with a combined 5-year survival rate of 80%. COG’s mission is to improve the cure rate and outcomes for all children with cancer.